The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.37
Bid: 1.365
Ask: 1.435
Change: -0.025 (-1.75%)
Spread: 0.07 (5.128%)
Open: 1.40
High: 1.40
Low: 1.30
Prev. Close: 1.425
QED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing Results, Open Offer & Posting of Circular

7 Jul 2023 10:38

RNS Number : 3588F
Quadrise PLC
07 July 2023
 

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN, INTO OR FROM THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE SAME WOULD BE UNLAWFUL.

 

7 July 2023

 

Quadrise plc

(the "Company" and together with its subsidiaries the "Group" or "Quadrise",)

 

Results of Placing, Open Offer Launch and Posting of Circular

 

Quadrise Plc (AIM:QED), the supplier of innovative energy solutions for a cleaner planet, is pleased to announce the successful results of the Placing announced on 7 July 2023 and to confirm the launch of the Open Offer to Qualifying Shareholders.

 

The Company has conditionally raised total gross proceeds of £1.1 million pursuant to the Placing of 88,000,000 Placing Shares at the Placing Price of 1.25 pence per New Ordinary Share. The gross proceeds of the Placing are expected to be supplemented by additional gross proceeds of up to £2.2 million to be raised pursuant to the Open Offer.

 

A circular containing detailed information about the Open Offer, including the terms and conditions and details on how to accept the Open Offer (the "Circular") and an accompanying Application Form (for Qualifying Non-CREST Shareholders) will shortly be posted to Shareholders.

 

A copy of the Circular will shortly be available from the Company's website at www.quadrise.com.

 

Capitalised terms used but not otherwise defined in this announcement bear the meanings ascribed to them in the Circular.

 

Open Offer

 

Pursuant to the Open Offer, Qualifying Shareholders will have an opportunity to subscribe for an aggregate of 175,863,121 new Ordinary Shares (the "Open Offer Shares") at 1.25 pence per Open Offer Share on the basis of:

 

1 Open Offer Share for every 8 Existing Ordinary Shares held on the Record Date

 

In addition, the Open Offer presents Qualifying Shareholders with an opportunity, provided that they take up their Basic Entitlements in full, to apply for additional Open Offer Shares through the Excess Application Facility. The Open Offer is not underwritten.

 

If Qualifying Shareholders do not take up all of the Open Offer Shares, the Company and the Bookrunners may agree (without any obligation to do so) that the Bookrunners should use their reasonable efforts to procure subscribers for such Open Offer Shares at the Issue Price. There is no guarantee that this will occur or that the Bookrunners would be successful in so procuring any subscribers for such Open Offer Shares.

 

Further details of the Open Offer are set out in the extract from the 'Letter from the Chairman of the Company' below, together with the expected timetable.

 

Director Placing participation and intended Open Offer participation

 

The following Directors and PDMRs of the Company have participated in the Placing or intend to participate in the Open Offer as follows:

 

Director/PDMR

Number of Existing Ordinary Shares

Number of Placing Shares subscribed for

Number of Ordinary Shares held on First Admission

Total number Open Offer Shares to be applied for*

Number of Ordinary Shares held on Second Admission**

Andy Morrison

700,000

2,400,000

3,100,000

-

3,100,000

Jason Miles

3,905,988

0

3,905,988

400,000

4,305,988

Laurie Mutch

522,107

0

522,107

160,000

682,107

Philip Snaith

506,649

0

506,649

240,000

746,649

David Scott

30,309

0

30,309

80,000

110,309

Philip Hill

-

160,000

160,000

-

160,000

 

* consisting in the case of all participating Directors/PDMRs of 100% uptake of their Basic Entitlements under the Open Offer and additional applications by each for Excess Shares under the Excess Application Facility.

 

** assuming that the applications of participating Directors/PDMRs for Excess Shares under the Excess Application Facility are satisfied in full.

 

The notification below, made in accordance with the requirements of the Market Abuse Regulation (EU) No. 596/2014 as it forms part of UK domestic law by virtue of the European Union (Withdrawal) Act 2018 and as modified by or under the European Union (Withdrawal) Act 2018 or other domestic law, provides further detail.

Admission and dealings

 

The Placing Shares and the Open Offer Share will, when issued, be credited as fully paid and will rank pari passu in all respects with each other and with the Existing Ordinary Shares.

 

Application has been made to the London Stock Exchange for the Placing Shares and Open Offer Shares to be admitted to trading on AIM. Settlement for the Placing Shares is expected to take place on or around 8.00 a.m. on 12 July 2023 ("First Admission") (or such later date as may be agreed between the Bookrunners, Cenkos and the Company). Settlement for the Open Offer Shares is expected to take place on or around 8.00 a.m. on 26 July 2023 ("Second Admission") (or such later date as may be agreed between the Bookrunners, Cenkos and the Company).

 

The Placing is conditional, inter alia, upon First Admission becoming effective and the Placing Agreement between the Company, the Bookrunners and Cenkos not being terminated in accordance with its terms. The Open Offer is conditional, inter alia, upon First Admission and Second Admission becoming effective.

 

Total voting rights

 

On First Admission, the Company will have a total of 1,494,904,968 Ordinary Shares in issue, with no Ordinary Shares held in treasury. Therefore, following First Admission, this figure may be used by Shareholders as the denominator for the calculations by which they determine if they are required to notify their interest in, or a change in their interest in, the Company under the Disclosure Guidance and Transparency Rules of the Financial Conduct Authority.

 

For further information contact:

 

Quadrise Plc

+44 (0)20 7031 7321

Andy Morrison, Chairman

Jason Miles, Chief Executive Officer

Nominated Adviser

Cenkos Securities plc

+44 (0)20 7397 8900

Ben Jeynes

Katy Birkin

Joint Brokers

Shore Capital Stockbrokers Limited

 

 

+44 (0)20 7408 4090

Toby Gibbs, Rachel Goldstein (Corporate Advisory)

Fiona Conroy (Corporate Broking)

 

 

 

VSA Capital Limited

Andrew Raca (Corporate Finance)

Andrew Monk (Corporate broking)

+44 (0)20 3005 5000

Public & Investor Relations

 

 

Vigo Consulting

Patrick D'Ancona

Charlie Neish

+44 (0)20 7390 0230

 

 

EXPECTED TIMETABLE OF PRINCIPAL EVENTS

 

Record Date for the Open Offer

 

6.00 p.m. on 6 July 2023

Announcement of the Placing

7 July 2023

 

 

Announcement of results of the Placing and launch of the Open Offer

 

 7 July 2023

Publication and posting of the Circular and the Application Form

 

10 July 2023

Existing Ordinary Shares marked 'ex' by London Stock Exchange

 

8.00 a.m. on 10 July 2023

Open Offer Entitlements and Excess CREST Open Offer Entitlements credited to stock accounts in CREST of Qualifying CREST Shareholders

 

as soon as practicable after

8.00 a.m. on 11 July 2023

 

First Admission effective and dealing in the Placing Shares commence on AIM

 

8.00 a.m. on 12 July 2023

CREST accounts credited in respect of Placing Shares

 

12 July 2023

Recommended latest time for requesting withdrawal of Open Offer

Entitlements and Excess CREST Open Offer Entitlements fromCREST

 

4.30 p.m. on 19 July 2023

Latest time for depositing Open Offer Entitlements and Excess 

CREST Open Offer Entitlements into CREST

 

3.00 p.m. on 20 July 2023

Latest time for splitting Application Forms (to satisfy bona fide market

claims only)

 

3.00 p.m. on 21 July 2023

Latest time and date for receipt of completed Application Forms and payment in full under the Open Offer and settlement of relevant CREST instructions (as appropriate)

 

11.00 a.m. on 25 July 2023

Expected date of announcement of the results of the Open Offer

 

25 July 2023

Second Admission effective and dealings in the Open Offer Shares commence on AIM

 

8.00 a.m. on 26 July 2023

CREST accounts credited in respect of Open Offer Shares

 

26 July 2023

Share certificates dispatched for the Fundraising Shares to be held in certificated form by

 

9 August 2023

The dates and timing of the events in the above timetable are indicative only and may be subject to change at the absolute discretion of the Company. If any of the details contained in the timetable above should change, the revised times and dates will be notified by means of an announcement through a Regulatory Information Service. All references are to London time unless stated otherwise.

Open Offer

 

Qualifying Shareholders are invited to apply for Open Offer Shares under the Open Offer at the Issue Price of 1.25 pence per Open Offer Share, payable in full on application and free of all expenses, pro rata to their existing shareholdings on the basis of:

 

1 Open Offer Share for every 8 Existing Ordinary Shares

 

held at the Record Date and so on in proportion for any other number of Existing Ordinary Shares then held. Open Offer Entitlements will be rounded down to the nearest whole number of Open Offer Shares. The Issue Price represents a discount of 34.2 per cent. to the closing mid-market price of 1.90 pence per Existing Ordinary Share on 6 July 2023, being the last practicable date prior to this announcement.

 

Qualifying Shareholders are also being given the opportunity, provided that they take up their Open Offer Entitlements in full, to apply for additional Open Offer Shares through the Excess Application Facility. Once subscriptions under the Open Offer Entitlements have been satisfied in full, the Company shall, in its absolute discretion, determine whether to meet any excess applications in full or in part, and no assurance can be given that applications by Qualifying Shareholders under the Excess Application Facility will be met in full or in part or at all.

 

To the extent that Open Offer Shares are not subscribed by Qualifying Shareholders, Open Offer Entitlements will lapse. Qualifying Shareholders may apply for more or less Open Offer Shares than they are entitled to under the Open Offer.

 

The Open Offer is subject to the satisfaction, inter alia, of the following conditions on or before 26 July 2023, or such later date as the Company and the Bookrunners may agree:

 

(i) the Placing and Open Offer Agreement becoming unconditional in all respects in relation to the Open Offer and not having been terminated in accordance with its terms; and

 

(ii) Admission becoming effective.

 

Accordingly, in the event that any of these conditions are not satisfied, or, if applicable, waived, by 26 July 2023 (or such later time as the Bookrunners and the Company may in their absolute discretion determine provided that such time does not extend beyond 5.00 pm on 9 August 2023) the Open Offer will not proceed. In such circumstances, application monies will be returned (at the applicant's sole risk), without payment of interest, as soon as practicable thereafter.

 

Fractions of Open Offer Shares will not be allotted to Qualifying Shareholders in the Open Offer and, where necessary, entitlements under the Open Offer will be rounded down to the nearest whole number of Open Offer Shares. Any fractional entitlement to Open Offer Shares will be disregarded in calculating Open Offer Entitlements.

 

Whilst Qualifying Shareholders with a shareholding of less than 8 Existing Ordinary Shares on the Record Date will not receive an Open Offer Entitlement, such Qualifying Shareholders will be able to apply for Open Offer Shares under the Excess Application Facility.

 

The participation of a Qualifying Shareholder in their Open Offer Entitlement and any Excess Shares under the Excess Application Facility does not guarantee that their percentage shareholding will not be diluted from the position prior to the Placing and Open Offer as a result of the issue of the Placing Shares.

 

The Open Offer Shares have not been and are not intended to be registered, offered or qualified for sale in United States, Canada, Australia, New Zealand, the Republic of South Africa or Japan or any other jurisdiction where such registration, offer or salle would be prohibited by applicable law (any such jurisdiction being an Excluded Jurisdiction). The securities referred to herein have not been and will not be registered under the US Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States or other Excluded Jurisdiction. Accordingly, unless otherwise determined by the Company and effected by the Company in a lawful manner, the Application Form will not be sent to Qualifying Non-CREST Shareholders with registered addresses in any Excluded Jurisdiction since to do so would require compliance with the relevant securities laws of that jurisdiction. Unless otherwise determined by the Company applications for the Open Offer from any person in an Excluded Jurisdiction will be deemed to be invalid.

 

The Open Offer Shares will, when issued and fully paid, rank pari passu in all respects with the Existing Adjusted Ordinary Shares, including the right to receive all dividends and other distributions declared, made or paid after the date of Second Admission.

 

Qualifying Shareholders should note that the Open Offer is not a rights issue and therefore the Open Offer Shares which are not applied for by Qualifying Shareholders will not be sold in the market for the benefit of the Qualifying Shareholders who do not apply under the Open Offer. Qualifying Non-CREST Shareholders should note the Application Form is not a document of title and cannot be traded or otherwise transferred.

 

Risk Factors

The attention of Shareholders is drawn to the risk factors set out in Part III of the Circular.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

 

a)

Name

1. Andrew Morrison

2. Phil Hill

2

Reason for notification

a)

Position/Status

1. Non-Executive Chairman

2. Chief Operating Officer

 

 

b)

Initial notification/amendment

Initial notification

 

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Quadrise plc

 

 

b)

LEI

213800HN2ETG5476U328

 

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument and identification code

Ordinary shares of 1 pence each

 

ISIN: GB00BM9CLS53

 

 

b)

Nature of transaction

Subscription for Placing Shares

 

 

c)

Price(s) and volume(s)

 Price(s)

Volume(s)

 

1.25 pence

1.25 pence

 

 

2,400,000

160,000

d)

Aggregated information

 n/a

 

 

e)

Date of transaction

7 July 2023

 

 

f)

Place of transaction

Outside of a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ROINKOBNCBKKOOK
Date   Source Headline
2nd May 20247:00 amRNSQuadrise-Vertoro JDA to sea-trial bioMSAR Zero
29th Apr 20247:00 amRNSMarine Project Update
19th Apr 20247:00 amRNSValkor Project Update
12th Apr 20244:58 pmRNSResults of Open Offer
22nd Mar 20243:10 pmRNSExtension of Open Offer Closing Date
20th Mar 20241:01 pmRNSInvestor Presentation
19th Mar 20247:00 amRNSPlacing Results, Open Offer & Posting of Circular
18th Mar 20244:55 pmRNSProposed Placing, Subscription and Open Offer
18th Mar 20244:53 pmRNSInterim Results
15th Feb 20247:00 amRNSAgreement with Euthenia & BTG Bioliquids
6th Feb 20247:00 amRNSMarine Project Update
6th Dec 20237:00 amRNSUpdate re bioMSARâ„¢ and bioMSARâ„¢ Zero Development
27th Nov 20235:46 pmRNSResult of AGM
27th Nov 20237:00 amRNSAGM Statement
22nd Nov 20237:00 amRNSMorocco Project Update
9th Nov 20237:00 amRNSPublication of 2023 Sustainability Report
31st Oct 202312:45 pmRNSMorocco Project Update
27th Oct 20234:20 pmRNSPosting of Annual Report & Notice of AGM
24th Oct 20239:33 amRNSChange of Nominated Adviser
2nd Oct 20237:30 amRNSDirectorate Change
2nd Oct 20237:00 amRNSFinal Results and Notice of AGM
12th Sep 20237:00 amRNSMorocco Project Update
29th Aug 20237:00 amRNSValkor Project Update
24th Aug 202312:29 pmRNSValkor Update
18th Aug 20233:46 pmRNSMorocco Update
4th Aug 20237:00 amRNSIssue of Share Options and Director/PDMR Dealing
1st Aug 20234:15 pmRNSDirector/PDMR Shareholding
28th Jul 20234:25 pmRNSDirector/PDMR Shareholding
25th Jul 20233:34 pmRNSResults of Open Offer
7th Jul 202312:00 pmRNSInvestor Presentation
7th Jul 202310:38 amRNSPlacing Results, Open Offer & Posting of Circular
7th Jul 20237:00 amRNSProposed Placing and Open Offer
22nd Jun 20237:00 amRNSMorocco Update
12th Jun 20237:00 amRNSValkor Site License & Supply Agreement
8th Jun 20237:00 amRNSJoint Development Agreement with BTG Bioliquids
26th May 20237:00 amRNSVertoro Joint Development Agreement Update
22nd May 20237:00 amRNSMorocco Update
16th May 20234:29 pmRNSReplacement: Business Update
16th May 20237:00 amRNSBusiness Update
25th Apr 20237:00 amRNSAppointment of Joint Broker
29th Mar 20237:00 amRNSInterim Results
28th Mar 20237:00 amRNSChange of Company Name
22nd Oct 20155:26 pmRNSDelisting of Quintain ordinary shares
15th Oct 20154:30 pmRNSHolding(s) in Company
15th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
13th Oct 20154:30 pmRNSHolding(s) in Company
8th Oct 201512:20 pmRNSCompulsory Acqn Procedure
5th Oct 20157:00 amRNSPosting of response circular to increased offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.